In the BioHarmony Drug Report Database
Dovonex, Sorilux (calcipotriene) is a small molecule pharmaceutical. Calcipotriene was first approved as Dovonex on 1993-12-29. It is used to treat psoriasis in the USA. The pharmaceutical is active against vitamin D3 receptor. Calcipotriene’s patents are valid until 2028-05-07 (FDA).
Image (chem structure or protein)